Anxiety Reduction in TAVI using Virtual Reality Trial
- Conditions
- Anxiety during TAVIAnxiety during transcatheter aortic valve replacement procedure under local anesthesia10046973
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 75
o Age * 18 years
o Symptomatic severe aortic stenosis
o Indication for transfemoral TAVI under local anaesthesia per local heart team
consensus
o Patient is able to understand and sign written informed consent
o Patient speaks Dutch, German or English
o Need for emergent TAVI
o Need for planned concomitant cardiac intervention during index procedure
o History of TAVI under local anesthesia/conscious sedation
o Chronic use of benzodiapines, opioids, pregabalin or antidepressants
o History of opioid use (within 8-30 days prior to randomization)
o Claustrophobia
o Any psychiatric illness diagnosed by a psychiatrist or psychologist
o Blindness or severe visual impairment despite visual aid (glasses, contact
lenses)
o Epilepsy
o Extensive cognitive impairment (MMSE <21 or as diagnosed by geriatrician)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Primary endpoint: Procedural anxiety assessed on a visual analogue scale (VAS)<br /><br>directly post-procedure.</p><br>
- Secondary Outcome Measures
Name Time Method <p>Patient procedural satisfaction<br /><br>Change in anxiety pre- vs. postprocedure<br /><br>Procedural pain assessed on a VAS directly post-procedure<br /><br>Procedural sedative use and dosage<br /><br>Procedural analgesic use and dosage<br /><br>Procedural nausea<br /><br>Procedural vomiting<br /><br>Admission time </p><br>